Patents by Inventor Livia Tepshi

Livia Tepshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12024508
    Abstract: The invention relates to a new family of compounds of the type 2,3-dihydroquinazolin-4(1H)-one and the use thereof as inhibitors of the toxic effects of intracellular-acting toxins, such as ricin, Shiga toxins or the cholera toxin, using retrograde transport to intoxicate the cells, or viruses or bacteria using retrograde and/or syntaxin 5-dependent transport to infect the cells, specifically viruses or bacteria entering into the cells by means of endocytosis, or intracellular parasites.
    Type: Grant
    Filed: November 28, 2019
    Date of Patent: July 2, 2024
    Assignee: Commissariat a l'Energie Atomique et aux Energies Alternatives
    Inventors: Jean-Christophe Cintrat, Julien Barbier, Daniel Gillet, Alain Pruvost, Audrey Couhert, Livia Tepshi, Robin Vinck
  • Publication number: 20220002289
    Abstract: The invention relates to a new family of compounds of the type 2,3-dihydroquinazolin-4(1H)-one and the use thereof as inhibitors of the toxic effects of intracellular-acting toxins, such as ricin, Shiga toxins or the cholera toxin, using retrograde transport to intoxicate the cells, or viruses or bacteria using retrograde and/or syntaxin 5-dependent transport to infect the cells, specifically viruses or bacteria entering into the cells by means of endocytosis, or intracellular parasites.
    Type: Application
    Filed: November 28, 2019
    Publication date: January 6, 2022
    Applicant: Commissariat a l'Energie Atomique et aux Energies Alternatives
    Inventors: Jean-Christophe Cintrat, Julien Barbier, Daniel Gillet, Alain Pruvost, Audrey Couhert, Livia Tepshi, Robin Vinck